Should you sell your Tilray stock?
Tilray Brands (TSX:TLRY) reported fiscal Q1 2027 revenue of $257.1M and Adjusted EBITDA of $9.2M, missing analyst estimates. Cannabis revenue fell 13% year-over-year, while beverage alcohol revenue rose 82.1%. Analyst Neal Gilmer maintained a 'Hold' rating and $4.00 target, citing concerns about organic growth and cash flow.
How this was made
The 30-second read
Why it matters
The earnings miss may trigger short‑term price weakness, but the company's diversified portfolio and cash balance could support a longer‑term hold stance.
Market read
Tilray's earnings miss is the primary market‑moving event; peers may be affected by sector sentiment.
What to watch
Cash position remains strong and debt manageable, providing runway for growth.
Background
Tilray Brands, a Canadian‑listed cannabis and beverage company, released its fiscal Q1 2027 results, which fell short of analyst expectations.
Ticker impact
Tilray Brands reported Q1 2027 revenue and adjusted EBITDA below analyst estimates, prompting a hold rating and unchanged $4 target.
likely modest downside pressure as the market prices in the revenue and EBITDA shortfall.
The miss on both top‑line and EBITDA versus consensus is a fresh primary disclosure; analysts kept a hold rating, suggesting limited upside and potential near‑term sell‑off.
Market effects
Cannabis sector may see broader scrutiny as Tilray's miss highlights pricing pressure.
Canadian cannabis market sentiment could soften.
Limited; impact confined to Tilray and peers.
Counterpoint
If the new cultivars and BrewDog beverage line sustain momentum, TLRY could rebound despite the short‑term miss.
Key entities
- companyTilray Brands
Cannabis and beverage alcohol producer listed on TSX and NASDAQ (TLRY).
- analyst_firmHaywood Securities
Provided the hold rating and $4 price target.
